SCHEMBL9041241

SCHEMBL9041241

OCc1cc(-c2ccc(F)cc2F)ccc1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 2/20 0.58
▸ ACMSD Q8TDX5 2/20 0.58
▸ KDM4E B2RXH2 1/20 0.58
▸ MEN1 O00255 1/20 0.58
▸ USP2 O75604 1/20 0.58
▸ ALDH1A1 P00352 1/20 0.58
▸ DHFR P00374 1/20 0.58
▸ CA1 P00915 1/20 0.58
▸ CA2 P00918 1/20 0.58
▸ LMNA P02545 1/20 0.58
▸ ALB P02768 1/20 0.58
▸ HMGB1 P09429 1/20 0.58
▸ HPGD P15428 1/20 0.58
▸ CXCL12 P48061 1/20 0.58
▸ KMT2A Q03164 1/20 0.58
▸ HIF1A Q16665 1/20 0.58
▸ SLC22A6 Q4U2R8 1/20 0.58
▸ HSD17B10 Q99714 1/20 0.58
▸ ESR1 P03372 2/20 0.42
▸ ESR2 Q92731 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13652987 0.85 TTR (0.60) TTRACMSDKDM4EMEN1USP2
SCHEMBL1906156 0.81 KLF10 (0.50) HIF1AKLF10CA3CA6CA5A
SCHEMBL412535 0.77 ESR1 (0.55) TTRACMSDKDM4EMEN1USP2
SCHEMBL13652985 0.77 TTR (0.59) TTRACMSDKDM4EMEN1USP2
SCHEMBL13652988 0.77 ALDH1A1 (0.59) TTRACMSDKDM4EMEN1USP2
SCHEMBL2760398 0.77 TTR (0.59) TTRACMSDKDM4EMEN1USP2
SCHEMBL14408194 0.77 TTR (0.59) TTRACMSDKDM4EMEN1USP2
SCHEMBL9057929 0.77 ALDH1A1 (0.52) TTRACMSDKDM4EMEN1USP2
SCHEMBL9418406 0.77 GABRA1 (0.56) HIF1AKLF10APPHSD17B1PKM
SCHEMBL19321459 0.74 MEN1 (0.49) TTRACMSDKDM4EMEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210169905-A1 FATTY ACID ACETYLATED SALICYLATES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. 2021-06-10 — — US disclosed
US-20200046738-A1 FATTY ACID ACETYLATED SALICYLATES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. 2020-02-13 — — US disclosed
US-10358452-B2 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof KEMPHARM, INC. (US) 2019-07-23 — — US disclosed
US-20170246193-A1 FATTY ACID ACETYLATED SALICYLATES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. 2017-08-31 — — US disclosed
US-20170143696-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USES THEREOF ALTER DOMUS (US) LLC 2017-05-25 — — US disclosed
EP-0537313-B1 ARYLALKYL ESTERS OF 4,5-DIHYDROXY-9,10-DIHYDRO-9,10-DIOXO-2-ANTHRACENECARBOXYLIC ACID HAVING THERAPEUTICAL ACTIVITY GENTILI IST SPA (IT) 1996-01-17 — — EP disclosed
US-5330981-A Antiinflammatory agents ISTITUTO GENTILI S.P.A. (IT) 1994-07-19 — — US disclosed
EP-0537313-A1 ARYLALKYL ESTERS OF 4,5-DIHYDROXY-9,10-DIHYDRO-9,10-DIOXO-2-ANTHRACENECARBOXYLIC ACID HAVING THERAPEUTICAL ACTIVITY. GENTILI IST SPA (IT) 1993-04-21 — — EP disclosed
EP-0254354-B1 PHARMACEUTICALLY USEFUL DERIVATIVES OF THIAZOLIDINE-4-CARBOXYLIC ACID ZAMBON S.p.A. (IT) 1993-03-31 — — EP disclosed
WO-1992019584-A1 ARYLALKYL ESTERS OF 4,5-DIHYDROXY-9,10-DIHYDRO-9,10-DIOXO-2-ANTHRACENECARBOXYLIC ACID HAVING THERAPEUTICAL ACTIVITY ISTITUTO GENTILI S.P.A. (IT) 1992-11-12 — — WO disclosed
US-4840936-A ANTIFLAMMATORY, ANALGESIC AGENT TO PREVENT ARRHYTHMIAS ZAMBON S.P.A. (IT) 1989-06-20 — — US disclosed
EP-0254354-A1 Pharmaceutically useful derivatives of thiazolidine-4-carboxylic acid ZAMBON S.p.A. (IT) 1988-01-27 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200046738-A1 FATTY ACID ACETYLATED SALICYLATES AND THEIR USES FASN, ACACA, FABP4 TTR 3296/4885ACMSD 585/4885KDM4E 2493/4885
US-20170143696-A1 BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USES THEREOF CYP2B6, CYP3A43, CYP2D6 TTR 2568/4885ACMSD 264/4885KDM4E 1814/4885
US-10358452-B2 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof CYP2B6, CYP3A43, CYP2D6 TTR 2568/4885ACMSD 264/4885KDM4E 1814/4885
US-20170246193-A1 FATTY ACID ACETYLATED SALICYLATES AND THEIR USES FASN, ACACA, FABP4 TTR 3296/4885ACMSD 585/4885KDM4E 2493/4885
US-20210169905-A1 FATTY ACID ACETYLATED SALICYLATES AND THEIR USES FASN, ACACA, FABP4 TTR 3296/4885ACMSD 585/4885KDM4E 2493/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback